194 related articles for article (PubMed ID: 36316775)
1. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.
Han SJ; Sung N; Wang J; O'Malley BW; Lonard DM
Breast Cancer Res; 2022 Oct; 24(1):73. PubMed ID: 36316775
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasion.
Han SJ; Jain P; Gilad Y; Xia Y; Sung N; Park MJ; Dean AM; Lanz RB; Xu J; Dacso CC; Lonard DM; O'Malley BW
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2221707120. PubMed ID: 37253006
[TBL] [Abstract][Full Text] [Related]
3. Steroid Receptor Coactivator-3 is a Key Modulator of Regulatory T Cell-Mediated Tumor Evasion.
Han SJ; Jain P; Gilad Y; Xia Y; Sung N; Park MJ; Dean AM; Lanz RB; Xu J; Dacso CC; Lonard DM; O'Malley BW
bioRxiv; 2023 Mar; ():. PubMed ID: 37034717
[TBL] [Abstract][Full Text] [Related]
4. Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma-tocotrienol supplementation.
Subramaniam S; Anandha Rao JS; Ramdas P; Ng MH; Kannan Kutty M; Selvaduray KR; Radhakrishnan AK
Clin Exp Immunol; 2021 Nov; 206(2):161-172. PubMed ID: 34331768
[TBL] [Abstract][Full Text] [Related]
5. ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells.
Regev O; Kizner M; Roncato F; Dadiani M; Saini M; Castro-Giner F; Yajuk O; Kozlovski S; Levi N; Addadi Y; Golani O; Ben-Dor S; Granot Z; Aceto N; Alon R
Front Immunol; 2022; 13():849701. PubMed ID: 35911772
[TBL] [Abstract][Full Text] [Related]
6. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
7. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
8. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
9. Exercise Training Improves Tumor Control by Increasing CD8
Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D
Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
Lee WK; Kim WG; Fozzatti L; Park S; Zhao L; Willingham MC; Lonard D; O'Malley BW; Cheng SY
Endocr Relat Cancer; 2020 Apr; 27(4):209-220. PubMed ID: 31977311
[TBL] [Abstract][Full Text] [Related]
11. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.
Huang Y; Ma C; Zhang Q; Ye J; Wang F; Zhang Y; Hunborg P; Varvares MA; Hoft DF; Hsueh EC; Peng G
Oncotarget; 2015 Jul; 6(19):17462-78. PubMed ID: 25968569
[TBL] [Abstract][Full Text] [Related]
12. Targeting Tumor Acidosis and Regulatory T Cells Unmasks Anti-Metastatic Potential of Local Tumor Ablation in Triple-Negative Breast Cancer.
Nief CA; Gonzales A; Chelales E; Agudogo JS; Crouch BT; Nair SK; Ramanujam N
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955613
[TBL] [Abstract][Full Text] [Related]
13. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
14. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
Manukian G; Kivolowitz C; DeAngelis T; Shastri AA; Savage JE; Camphausen K; Rodeck U; Zarif JC; Simone NL
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1341-1349. PubMed ID: 33647370
[TBL] [Abstract][Full Text] [Related]
15. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
[TBL] [Abstract][Full Text] [Related]
16. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.
Kaneko K; Acharya CR; Nagata H; Yang X; Hartman ZC; Hobeika A; Hughes PF; Haystead TAJ; Morse MA; Lyerly HK; Osada T
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171008
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.
Pellom ST; Dudimah DF; Thounaojam MC; Uzhachenko RV; Singhal A; Richmond A; Shanker A
Oncotarget; 2017 Jan; 8(5):8604-8621. PubMed ID: 28052005
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer.
Aida K; Miyakawa R; Suzuki K; Narumi K; Udagawa T; Yamamoto Y; Chikaraishi T; Yoshida T; Aoki K
Cancer Sci; 2014 Feb; 105(2):159-67. PubMed ID: 24289533
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
Qin Y; Vasilatos SN; Chen L; Wu H; Cao Z; Fu Y; Huang M; Vlad AM; Lu B; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2019 Jan; 38(3):390-405. PubMed ID: 30111819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
